BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PPARA
,
Fatty acid metabolic process
,
Pseudomonas infection
,
Lung
,
Biofuel
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
imidazoline 1)- receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
QSAR study of selective I1-imidazoline receptor ligands.
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasag…
Effect of moxonidine on the uveoscleral outflow: role of alpha2-adrenoceptors or i1 imidazoline rece…
G-protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidaz…
Improvement of hyperphagia by activation of cerebral I(1)-imidazoline receptors in streptozotocin-in…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome
Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenor…
I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ